herbied47
4 weeks ago
Swing idea. AZTR small float, recently received study may proceed letter from the FDA for INDA to treat skin rash from EGFR inhibitors, , recent offering at 1.50, recently announced three newly patents in US, China and Canada to treat inflammatory skin diseases, recent 1/30 reverse split, Maxim Group Buy rating, price target $3
Invest-in-America
4 weeks ago
XPON: Indeed, my (East Coast) Pal of years now, Ms. GAIL!!! (Hey, excuse my belated REPLY here, due to long-over-due HUGE RAIN over here!!! First in months!!! And, naturally, the rest of Calif. burning to the ground this time of year!!)